Cosmetic oculofacial applications of botulinum toxin: a report by the American Academy of Ophthalmology
- PMID: 15936443
- DOI: 10.1016/j.ophtha.2005.03.021
Cosmetic oculofacial applications of botulinum toxin: a report by the American Academy of Ophthalmology
Abstract
Objective: To determine the safety and effectiveness of botulinum toxin for cosmetic oculofacial use.
Methods: Literature searches for relevant citations were conducted in October 2003 for the years 1965 to 2003. The panel reviewed and rated the articles for study design, methods, and results.
Results: Randomized double-masked controlled studies showed statistically significant improvement in glabellar, frontal, and lateral canthal rhytids (wrinkles) when injected with botulinum toxin. Standardized documentation using photographs and masked grading by the patient and physician support the efficacy of botulinum toxin for treatment of dynamic rhytids in the glabellar region, forehead, and lateral canthal area. Complications and adverse effects associated with treatment are infrequent and short lived.
Conclusions: Botulinum toxin is safe in the short term and effective in the temporary treatment of glabellar, frontal, and lateral canthal rhytids. Potential functional complications should be discussed with patients who are seeking cosmetic rejuvenation of the periocular and facial region. Further research is needed to determine the ideal effective dose for particular anatomic areas, ideal concentration, applicable doses across the different serotypes of botulinum toxin, duration of effect, changes in efficacy (if any) over extended periods of treatment, and long-term safety.
Similar articles
-
Cosmetic applications of botulinum toxin in oculofacial region.Acta Clin Croat. 2010 Dec;49(4):525-8. Acta Clin Croat. 2010. PMID: 21830467 Review.
-
Cosmetic upper-facial rejuvenation with botulinum.J Otolaryngol. 1997 Apr;26(2):92-6. J Otolaryngol. 1997. PMID: 9106083 Clinical Trial.
-
Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.Arch Dermatol. 2006 Mar;142(3):320-6. doi: 10.1001/archderm.142.3.320. Arch Dermatol. 2006. PMID: 16549707 Clinical Trial.
-
Botulinum toxin A: a review of 1,085 oral and maxillofacial patient treatments.J Oral Maxillofac Surg. 2003 Mar;61(3):317-24. doi: 10.1053/joms.2003.50069. J Oral Maxillofac Surg. 2003. PMID: 12618971
-
Understanding botulinum toxin. Surgical anatomy of the frown, forehead, and periocular region.Dermatol Surg. 1998 Nov;24(11):1172-4. Dermatol Surg. 1998. PMID: 9834734 Review.
Cited by
-
Noncosmetic periocular therapeutic applications of botulinum toxin.Middle East Afr J Ophthalmol. 2010 Apr;17(2):113-20. doi: 10.4103/0974-9233.63069. Middle East Afr J Ophthalmol. 2010. PMID: 20616916 Free PMC article.
-
[New botulinum toxins for aesthetic dermatology : A comprehensive review].Hautarzt. 2021 May;72(5):393-402. doi: 10.1007/s00105-021-04801-9. Epub 2021 Apr 6. Hautarzt. 2021. PMID: 33822278 Review. German.
-
Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines.Graefes Arch Clin Exp Ophthalmol. 2019 Feb;257(2):331-338. doi: 10.1007/s00417-018-4194-3. Epub 2018 Dec 14. Graefes Arch Clin Exp Ophthalmol. 2019. PMID: 30552510 Clinical Trial.
-
Periocular Aging Across Populations and Esthetic Considerations: A Narrative Review.J Clin Med. 2025 Jan 16;14(2):535. doi: 10.3390/jcm14020535. J Clin Med. 2025. PMID: 39860540 Free PMC article. Review.
-
Duration of Clinical Efficacy of OnabotulinumtoxinA in Crow's Feet Lines: Results from Two Multicenter, Randomized, Controlled Trials.Dermatol Surg. 2016 May;42(5):598-607. doi: 10.1097/DSS.0000000000000757. Dermatol Surg. 2016. PMID: 27110893 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical